SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Sumi Biswas

President, Co-founder, Chief Scientific Officer

Sumi Biswas

Sumi is a highly qualified immunologist with a compelling vision to apply our protein superglue technology to commercial vaccines development and production. She leads on both the scientific and strategic business development of the company.

Sumi combines a deep understanding of the relevant science with an interest in business and a talent for mobilizing teams around an inspiring purpose - qualities that were instrumental in securing initial investment for SpyBiotech. In 2017 she was named as a rising star in BioBeat’s Movers and Shakers list of 50 inspirational women in the BioTech industry.

Sumi moved to the UK in 2005 having studied microbiology at the University of Bangalore. She rose to become an Associate Professor of Vaccinology at the Jenner Institute, Oxford University’s world-leading vaccines innovation center, where two of the malaria vaccine candidates against malaria developed by her investigatory team are currently being taken into human clinical trials.

Back to team

Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline